Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02939209Phase 4Completed
Phase 4, randomised, double-blind trial in postoperative pain comparing Hydromorphone with Placebo (2 arms). Primary endpoint: Worst pain score at 24 hours. Started Apr 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02939209.